UNLEARN.AIbuyer room · privateManage buyer room
A model asset rather than a raw corpus: trained generative digital-twin models that forecast an individual participant's clinical outcome trajectory, built per therapeutic area from sponsor clinical trial data and natural-history data. Published evidence areas include ALS, Alzheimer's and a pan-cancer foundation model. The licensable artefacts are the fitted patient-progression generators, the synthetic control/cohort populations they emit, and the validation evidence set that was used to demonstrate twin accuracy against real trial arms
Get notified as soon as Unlearn.AI publishes. Until then, discover alternatives today with a 7-day trial.